Association Between Ménière's Disease and Thyroid Disease: A Systematic Review and Meta-Analysis.

Rui Lai, Liwen Tang, Tingting Zhu, Qiang Li
Author Information
  1. Rui Lai: Department of Otorhinolaryngology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. ORCID
  2. Liwen Tang: Department of Otorhinolaryngology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. ORCID
  3. Tingting Zhu: Department of Otorhinolaryngology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. ORCID
  4. Qiang Li: Department of Otorhinolaryngology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. ORCID

Abstract

OBJECTIVES: The relationship between Thyroid Disease and Ménière's disease (MD) remains controversial. This article aims to explore the association between Thyroid Disease and MD and provide new evidence for the prevention and treatment of MD and its complications.
DESIGN: A systematic review and meta-analysis.
METHODS: PubMed, EMBASE, Web of Science and Cochrane Library were searched until July 08, 2024. Based on the eligibility criteria, the literature was screened, the data were extracted, and the study quality was evaluated. The prevalence and/or incidence of MD in Thyroid Disease and the prevalence and/or incidence of Thyroid Disease in MD were explored. The pooled proportion with 95% confidence interval (CI) was calculated using a random-effects model.
RESULTS: Eighteen eligible studies were finally enrolled. A total of 14 studies mentioned the prevalence of Thyroid Disease in MD, with a pooled prevalence rate of 8%. Two studies reported the prevalence of MD in thyroid patients, with a pooled prevalence rate of 22%. Four studies explored the incidence of Thyroid Disease in MD, with a combined incidence rate of 23%. Thyroid hormone treatment not only improved hypothyroidism symptoms but also MD.
CONCLUSIONS: There is a significant association between Thyroid Disease and MD. Symptoms of hypothyroidism and MD can be improved after thyroid hormone treatment. The available evidence is limited, and more prospective and high-quality studies are required for validation.

Keywords

References

  1. A. Nacci, I. Dallan, F. Monzani, et al., “Elevated Antithyroid Peroxidase and Antinuclear Autoantibody Titers in Ménière's Disease Patients: More Than a Chance Association?,” Audiology & Neuro‐Otology 15, no. 1 (2010): 1–6, https://doi.org/10.1159/000218357.
  2. G. J. Basura, M. E. Adams, A. Monfared, et al., “Clinical Practice Guideline: Ménière's Disease,” Otolaryngology and Head and Neck Surgery 162, no. 2_suppl (2020): S1–S55.
  3. M. Brenner, D. L. Hoistad, and T. C. Hain, “Prevalence of Thyroid Dysfunction in Patients With Ménière's Disease,” Archives of Otolaryngology—Head & Neck Surgery 130, no. 2 (2004): 226–228.
  4. M. H. Kim, “Population‐Based Study for the Comorbidities and Associated Factors in Ménière's Disease,” Scientific Reports 12, no. 1 (2022): 8266.
  5. F. Mammarella, A. Loperfido, E. G. Keeling, G. Bellocchi, and L. Marsili, “Ménière's Disease: Insights From an Italian Nationwide Survey,” Audiology Research 13, no. 2 (2023): 160–168.
  6. P. N. Taylor, D. Albrecht, A. Scholz, et al., “Global Epidemiology of Hyperthyroidism and Hypothyroidism,” Nature Reviews. Endocrinology 14, no. 5 (2018): 301–316.
  7. M. P. Vanderpump, “The Epidemiology of Thyroid Disease,” British Medical Bulletin 99 (2011): 39–51.
  8. L. Chiovato, F. Magri, and A. Carlé, “Hypothyroidism in Context: Where We've Been and Where We're Going,” Advances in Therapy 36, no. Suppl 2 (2019): 47–58.
  9. N. Daramjav, J. Takagi, H. Iwayama, et al., “Autoimmune Thyroiditis Shifting From Hashimoto's Thyroiditis to Graves' Disease,” Medicina 59, no. 4 (2023): 757.
  10. K. Hughes and C. Eastman, “Thyroid Disease: Long‐Term Management of Hyperthyroidism and Hypothyroidism,” Australian Journal of General Practice 50, no. 1–2 (2021): 36–42.
  11. J. T. Vrabec, “Genetic Investigations of Meniere's Disease,” Otolaryngologic Clinics of North America 43, no. 5 (2010): 1121–1132.
  12. A. M. Parra‐Perez and J. A. Lopez‐Escamez, “Types of Inheritance and Genes Associated With Familial Meniere Disease,” Journal of the Association for Research in Otolaryngology 24, no. 3 (2023): 269–279.
  13. J. A. Lopez‐Escamez and Y. Liu, “Epidemiology and Genetics of Meniere's Disease,” Current Opinion in Neurology 37, no. 1 (2024): 88–94.
  14. W. H. Powers, “Metabolic Aspects of Ménière's Disease,” Laryngoscope 88, no. 1 Pt 1 (1978): 122–129.
  15. S. Y. Kim, Y. S. Song, J. H. Wee, C. Min, D. M. Yoo, and H. G. Choi, “Association Between Ménière's Disease and Thyroid Diseases: A Nested Case–Control Study,” Scientific Reports 10, no. 1 (2020): 18224.
  16. R. Teggi, R. A. Battista, F. di Berardino, et al., “Evaluation of a Large Cohort of Adult Patients With Ménière's Disease: Bedside and Clinical History,” Acta Otorhinolaryngologica Italica 40, no. 6 (2020): 444–449.
  17. B. Fattori, A. Nacci, A. Dardano, et al., “Possible Association Between Thyroid Autoimmunity and Menière's Disease,” Clinical and Experimental Immunology 152, no. 1 (2008): 28–32.
  18. G. A. Wells, D. O'Connell, J. Peterson, V. Welch, M. Losos, and P. Tugwell, “The Newcastle‐Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta‐Analyses,” http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  19. Z. Munn, S. Moola, C. Tufanaru, et al., “Methodological Quality of Case Series Studies,” JBI Evidence Synthesis 18, no. 10 (2020): 2127, https://doi.org/10.11124/JBISRIR‐D‐19‐00099.
  20. S. E. Kinney, “The Metabolic Evaluation in Meniere's Disease,” Otolaryngology and Head and Neck Surgery 88, no. 5 (1979): 594–598.
  21. W. L. Meyerhoff, M. M. Paparella, and F. K. Gudbrandsson, “Clinical Evaluation of Ménière's Disease,” Laryngoscope 91, no. 10 (1981): 1663–1668.
  22. A. Quaranta, C. Amoroso, G. C. Ettorre, and F. Violante, “Clinical and Radiological Findings in Subjects With Unilateral Ménière's Disorder,” Clinical Otolaryngology and Allied Sciences 7, no. 1 (1982): 29–34.
  23. I. Gazquez, A. Soto‐Varela, I. Aran, et al., “High Prevalence of Systemic Autoimmune Diseases in Patients With Menière's Disease,” PLoS One 6, no. 10 (2011): e26759.
  24. L. Frejo, A. Soto‐Varela, S. Santos‐Perez, et al., “Clinical Subgroups in Bilateral Meniere Disease,” Frontiers in Neurology 7 (2016): 182.
  25. U. P. Santosh and M. S. Rao, “Incidence of Hypothyroidism in Meniere's Disease,” Journal of Clinical and Diagnostic Research 10, no. 5 (2016): Mc01‐3.
  26. S. G. Bruderer, D. Bodmer, N. A. Stohler, S. S. Jick, and C. R. Meier, “Population‐Based Study on the Epidemiology of Ménière's Disease,” Audiology & Neuro‐Otology 22, no. 2 (2017): 74–82.
  27. W. L. Lin, C. Y. Chen, T. Y. Hsu, W. K. Chen, C. L. Lin, and H. C. Chen, “Hypothyroidism is an Independent Risk Factor for Menière's Disease: A Population‐Based Cohort Study,” Medicine (Baltimore) 98, no. 15 (2019): e15166.
  28. A. Bakdounes, N. Akashe, M. O. Alchallah, et al., “Prevalence of Ménière's Disease in Syrian Patients With Hypothyroidism: Cross‐Sectional Study,” Annals of Medicine and Surgery 81 (2022): 104405.
  29. K. Miśkiewicz‐Orczyk, A. Vlaykov, G. Lisowska, J. Strzelczyk, and B. Kos‐Kudła, “Does Thyroid Hormone Metabolism Correlate With the Objective Assessment of the Vestibular Organ in Patients With Vertigo?,” Journal of Clinical Medicine 11, no. 22 (2022): 6771.
  30. Committee on Hearing and Equilibrium, “Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Menière's Disease,” American Academy of Otolaryngology‐Head and Neck 113, no. 3 (1995): 181–185.
  31. J. A. Lopez‐Escamez, J. Carey, W. H. Chung, et al., “Diagnostic Criteria for Menière's Disease,” Journal of Vestibular Research 25, no. 1 (2015): 1–7.
  32. H. Vargas‐Uricoechea, “Molecular Mechanisms in Autoimmune Thyroid Disease,” Cells 12, no. 6 (2023): 918.
  33. S. M. Ferrari, F. Ragusa, G. Elia, et al., “Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism,” Frontiers in Pharmacology 12 (2021): 750380.
  34. F. Ragusa, P. Fallahi, G. Elia, et al., “Hashimotos' Thyroiditis: Epidemiology, Pathogenesis, Clinic and Therapy,” Best Practice & Research. Clinical Endocrinology & Metabolism 33, no. 6 (2019): 101367.
  35. D. J. Stuijver, B. van Zaane, E. Romualdi, D. P. Brandjes, V. E. Gerdes, and A. Squizzato, “The Effect of Hyperthyroidism on Procoagulant, Anticoagulant and Fibrinolytic Factors: A Systematic Review and Meta‐Analysis,” Thrombosis and Haemostasis 108, no. 6 (2012): 1077–1088, https://doi.org/10.1160/TH12‐07‐0496.
  36. A. Squizzato, E. Romualdi, H. R. Büller, and V. E. Gerdes, “Clinical Review: Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic Review,” Journal of Clinical Endocrinology and Metabolism 92, no. 7 (2007): 2415–2420.
  37. A. Jabbar, A. Pingitore, S. H. Pearce, A. Zaman, G. Iervasi, and S. Razvi, “Thyroid Hormones and Cardiovascular Disease,” Nature Reviews Cardiology 14, no. 1 (2017): 39–55.
  38. L. Frejo and J. A. Lopez‐Escamez, “Cytokines and Inflammation in Meniere Disease,” Clinical and Experimental Otorhinolaryngology 15, no. 1 (2022): 49–59.
  39. L. Girasoli, D. Cazzador, R. Padoan, et al., “Update on Vertigo in Autoimmune Disorders, From Diagnosis to Treatment,” Journal of Immunology Research 2018 (2018): 5072582.
  40. B. S. Oberman, V. A. Patel, S. Cureoglu, and H. Isildak, “The Aetiopathologies of Ménière's Disease: A Contemporary Review,” Acta Otorhinolaryngologica Italica 37, no. 4 (2017): 250–263.
  41. L. Riente, F. Bongiorni, A. Nacci, et al., “Antibodies to Inner Ear Antigens in Meniere's Disease,” Clinical and Experimental Immunology 135, no. 1 (2004): 159–163.
  42. R. De Luca, P. J. Davis, H.‐Y. Lin, et al., “Thyroid Hormones Interaction With Immune Response, Inflammation and Non‐Thyroidal Illness Syndrome,” Frontiers in Cell and Developmental Biology 8 (2020): 614030.
  43. J. A. Lopez‐Escamez, J. Vela, and L. Frejo, “Immune‐Related Disorders Associated With Ménière's Disease: A Systematic Review and Meta‐Analysis,” Otolaryngology and Head and Neck Surgery 169, no. 5 (2023): 1122–1131.
  44. T. H. Alexander and J. P. Harris, “Current Epidemiology of Meniere's Syndrome,” Otolaryngologic Clinics of North America 43, no. 5 (2010): 965–970.
  45. L. Frejo and J. A. Lopez‐Escamez, “Recent Advances in Understanding Molecular Bases of Ménière's Disease,” Faculty Reviews 12 (2023): 11.

Word Cloud

Created with Highcharts 10.0.0thyroidMDdiseaseprevalencestudiesincidenceMénière'streatmentpooledratehypothyroidismassociationevidenceand/orexploredThyroidhormoneimprovedOBJECTIVES:relationshipremainscontroversialarticleaimsexploreprovidenewpreventioncomplicationsDESIGN:systematicreviewmeta-analysisMETHODS:PubMedEMBASEWebScienceCochraneLibrarysearchedJuly082024Basedeligibilitycriterialiteraturescreeneddataextractedstudyqualityevaluatedproportion95%confidenceintervalCIcalculatedusingrandom-effectsmodelRESULTS:Eighteeneligiblefinallyenrolledtotal14mentioned8%Tworeportedpatients22%Fourcombined23%symptomsalsoCONCLUSIONS:significantSymptomscanavailablelimitedprospectivehigh-qualityrequiredvalidationAssociationDiseaseDisease:SystematicReviewMeta-Analysisautoimmunemeta‐analysisdiseases

Similar Articles

Cited By

No available data.